ED Drugs and Melanoma Risk

Patients taking medications for erectile dysfunction (ED) may have an increased risk of melanoma but these drugs are not a cause of melanoma.

Chili Pepper Toxin, Gallbladder Cancer Risk

Gallbladder cancer seems to be associated with aflatoxin, according to a new study.

No Link Between PTSD, Cancer

While the potential relationship between stress and cancer has been a topic of discussion and research for over 70 years, no association between post-traumatic stress disorder (PTSD) and cancer was found in the largest study to date.

Cyramza Gains Colon Cancer Indication

The FDA has expanded the indication of Cyramza (ramucirumab; Eli Lilly) for use in combination with irinotecan, folinic acid, and 5-fluorouracil (FOLFIRI) for the treatment of patients with metastatic colorectal cancer (mCRC) whose disease has progressed on a first line bevacizumab-, oxaliplatin- and fluoropyrimidine-containing regimen.

Fish Oil May Hinder Chemotherapy Effectiveness

Fish oil supplements, and even certain fish, may hinder the effectiveness of chemotherapy.

Stroke Risk Up After Cancer Diagnosis

Cancer increases the risk of stroke independently of other stroke risk factors, such as hypertension and diabetes.

Looking for a Job?

Access our job board to view over 1,​40​0 job openings throughout the US.

News

Six Lots of Cancer Drug Adrucil Recalled

Six Lots of Cancer Drug Adrucil Recalled

Teva announced a voluntary recall of 6 lots of Adrucil (fluorouracil injection) 5g/100mL (50mg/mL) due to potential particulate matter identified as aggregate of silicone rubber pieces from a filler diaphragm and fluorouracil crystals.

Kyprolis Gains Expanded Multiple Myeloma Indication

Kyprolis Gains Expanded Multiple Myeloma Indication

The FDA has approved Kyprolis (carfilzomib; Amgen) in combination with lenalidomide and dexamethasone for the treatment of patients with relapsed multiple myeloma who have received 1-3 prior lines of therapy.

Odomzo Approved for Advanced Skin Cancer

Odomzo Approved for Advanced Skin Cancer

Novartis announced that the Food and Drug Administration (FDA) has approved Odomzo (sonidegib) capsules for the treatment of adults with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates for surgery or radiation therapy.

Aromatase Inhibitors, Bisphosphonates Boost Survival in Some Early Breast Cancers

Aromatase Inhibitors, Bisphosphonates Boost Survival in Some Early Breast Cancers

Researchers found benefit from aromatase inhibitors and bisphosphonates

Evidence of Cellular Damage From CT Scans

Evidence of Cellular Damage From CT Scans

But whether this could trigger cancer or other health issues remains unclear

Charts

Make prescribing decisions with our comparative charts and treatment algorithms.

Patient Information Fact Sheets

Download or print easy-to-read disease leaflets for your patients.

Featured courses from myCME

Comprehensive Review of Radiation OncologyExternal web site

Radiation oncologists and residents will appreciate the experience of the renowned faculty of the Comprehensive ...

CME 24.00 Credits

Chronic Pain ManagementExternal web site

This activity is designed to change health provider attitudes on chronic pain and willingness to ...

CME|CE 2.00 Credits

Cannabinoid Offers Modest Relief From Pain, SpasticityExternal web site

Among the many issues clinicians face today, staying current with advances in medicine is becoming ...

CME|CE 0.25 Credits

Sign Up for Free e-newsletters